Mediolanum SpAMED:MIL

5.73
0.11 / 1.80%
651.49k
7.00%
1.29
Latest price in EURToday's changeShares traded1 year changeBeta
Data delayed at least 30 minutes, as of Aug 28 2014 11:42 BST.

Summary

As of last trade , Mediolanum SpA (MED:MIL) traded at 5.73, 12.02% above the 52 week low of 5.12 set on Aug 08, 2014.

52-week range
Today
5.12
Aug 08 2014
7.19
Apr 04 2014
Markit short selling activity
Low
Medium
High
Open5.83
Day high5.84
Day low5.73
Bid5.73
Offer5.74
Previous close5.84
Average volume1.38m
Shares outstanding736.85m
Free float209.95m
P/E (TTM)14.36
Market cap4.30bn EUR
EPS (TTM)0.4063 EUR
Annual div (TTM)0.20 EUR
Annual div yield (TTM)3.43%
Div ex-dateMay 19 2014
Div pay-dateMay 22 2014
Data delayed at least 30 minutes, as of Aug 28 2014 11:42 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Mediolanum SpA+2.50%-3.94%-14.22%+7.00%+28.91%
FTSE MIB IDX+2.23%-2.31%+0.67%+22.18%-9.77%
IT/FINANCIALS+4.78%+0.90%-0.46%+24.71%--
IT/INSURANCE+2.43%+2.60%-2.69%+7.41%--
Data delayed at least 30 minutes, as of Aug 28 2014 11:42 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.